Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 2/20 | 0.38 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.38 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.37 |
| ▸ | ALOX5AP | P20292 | 3/20 | 0.36 |
| ▸ | FEN1 | P39748 | 3/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | PDE2A | O00408 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26013450 | 0.93 | SOS1 (0.40) | BACE1NUDT1GABRA1GABRB2SOS1 | |
| SCHEMBL765783 | 0.81 | BACE1 (0.41) | BACE1NUDT1SOS1ALOX5APFEN1 | |
| SCHEMBL12329238 | 0.79 | NUDT1 (0.45) | BACE1NUDT1SOS1ALOX5APFEN1 | |
| SCHEMBL14297935 | 0.78 | BACE1 (0.44) | BACE1NUDT1SOS1RXRAGRIN1 | |
| SCHEMBL26032266 | 0.78 | NUDT1 (0.47) | BACE1NUDT1SOS1ALOX5APFEN1 | |
| SCHEMBL26016942 | 0.77 | NOS3 (0.40) | BACE1NUDT1SOS1ALOX5APFEN1 | |
| SCHEMBL14314452 | 0.77 | NUDT1 (0.46) | BACE1NUDT1SOS1 | |
| SCHEMBL12192825 | 0.77 | FFAR1 (0.45) | — | |
| SCHEMBL12192820 | 0.76 | FFAR1 (0.45) | — | |
| SCHEMBL12191917 | 0.76 | FFAR1 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023154291-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-08-17 | — | — | WO | disclosed |